Characterization of novel oral splicing modulator, H3B-8800, identifies the mechanistic basis for its preferential lethality towards spliceosome-mutant myeloid malignancy models Meeting Abstract

  

Authors:	Buonamici, S.; Yoshimi, A.; Thomas, M.; Seiler, M.; Chan, B.; Csibi, A.; Fekkes, P.; Klimek, V.; Kumar, P.; Lee, S. C. W.; Padron, E.; Pazolli, E.; Goldberg, J.; Sahmoud, T.; Taylor, J.; Warmuth, M.; Yu, L.; Zhu, P.; Abdel-Wahab, O.; Smith, P.
Abstract Title:	Characterization of novel oral splicing modulator, H3B-8800, identifies the mechanistic basis for its preferential lethality towards spliceosome-mutant myeloid malignancy models
Meeting Title:	14th International Symposium on Myelodysplastic Syndromes (MDS)
Journal Title:	Leukemia Research
Volume:	55
Issue:	Suppl. 1
Meeting Dates:	2017 May 3-6
Meeting Location:	Valencia, Spain
ISSN:	0145-2126
Publisher:	Elsevier Ltd
Date Published:	2017-04-01
Start Page:	S11
Language:	English
ACCESSION:	WOS:000417653300021
PROVIDER:	wos
DOI:	10.1016/S0145-2126(17)30133-9
Notes:	Meeting Abstract: 20 -- 14th International Symposium on Myelodysplastic Syndromes (MDS) -- MAY 03-06, 2017 -- Valencia, SPAIN -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/120275